Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Synthetic Protein Could Be Used to Make Artificial Blood

By LabMedica International staff writers
Posted on 16 Apr 2009
Using design and engineering principles learned from nature, a team of biochemists has constructed--from scratch--an entirely new type of protein. More...


Most proteins are "large" and full of interdependent branches, bends, and pockets in their final folded structure. This complexity aggravates biochemists and protein engineers trying to understand protein structure and function in order to reproduce or create new uses for these natural molecules to combat diseases or for use in industry.

The new type of protein can transport oxygen, similar to human neuroglobin, a molecule that carries oxygen in the brain and peripheral nervous system. In the future, this approach could be used to make artificial blood for use on the battlefield or by emergency-care professionals. The study's findings were published in the March 19, 2009, issue of the journal Nature.

"This is quite a different way of making novel proteins than the rest of the world," stated senior author P. Leslie Dutton, Ph.D., professor of biochemistry and biophysics at the University of Pennsylvania School of Medicine (Penn; Philadelphia, USA). "We've created an unusually simple and relatively small protein that has a function, which is to carry oxygen. No one else has ever done this before."

"Our aim is to design new proteins from principles we discover studying natural proteins," explained coauthor Christopher C. Moser, Ph.D., associate director of the Johnson Foundation at Penn. "For example, we found that natural proteins are complex and fragile and when we make new proteins we want them to be simple and robust. That's why we're not reengineering a natural protein, but making one from scratch."

Currently, protein engineers take an existing biochemical scaffold from nature and change it a bit structurally to make it do something else. "This research demonstrates how we used a set of simple design principles, which challenge the kind of approaches that have been used to date in reproducing natural protein functions," said Dr. Dutton.

The natural design of proteins ultimately lies in their underlying sequence of amino acids; organic compounds that link together to make proteins. In living organisms, this sequence is dictated by the genetic information carried in DNA within chromosomes. This information is then encoded in messenger RNA, which is transcribed from DNA in the nucleus of the cell. The sequence of amino acids for a specific protein is determined by the sequence of nucleotides in messenger RNA. It is the order of the amino acids and the chemical bonds between them that determine how a protein folds into its final shape.

To build their protein, the Penn researchers began with just three amino acids, which code for a helix-shaped column. From this, they assembled a four-column bundle with a loop that resembles a simple candelabrum. They added a heme, a chemical group that contains an iron atom, to bind oxygen molecules. They also added another amino acid called glutamate to add strain to the candelabra to help the columns open up to capture the oxygen. Since heme and oxygen degrade in water, the researchers also designed the exteriors of the columns to deter water to protect the oxygen payload inside.

At first, the team used a synthesizer--a robot that chemically sticks amino acids together in a desired sequence--to make the helix-shaped columns. "We do the first reactions with the robot to figure out the sequence of amino acids that we want," stated Dr. Moser. When they were satisfied with the sequence, they used the bacterium Escherichia coli as a biologic host to make the full protein.

The scientists used chemical tests to validate that their protein did indeed capture oxygen. When the oxygen did bind to the iron heme molecule in the artificial protein, the solution in which the reaction occurred changed color from dark red to scarlet, a color signature almost identical to natural neuroglobin. "This exercise is like making a bus," said Dr. Dutton. "First you need an engine and we've produced an engine. Now we can add other things on to it. Using the bound oxygen to do chemistry will be like adding the wheels. Our approach to building a simple protein from scratch allows us to add on, without getting more and more complicated."

Related Links:

University of Pennsylvania School of Medicine




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.